MAI Capital Management

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1040197 INDEPENDENCE, OH

Position in TAK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$164,979

+$111,364 QoQ

Shares Held

10,292

+255.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#227

of 375 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MAI Capital Management holds $5,871,377 across 11 Drug Manufacturers - Specialty & Generic names. TAK ranks #8 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	24,462	$1,757,838
2	NBIX	Neurocrine Biosciences Inc	8,096	$1,364,498
3	UTHR	UNITED THERAPEUTICS Corp	1,934	$1,047,898
4	VTRS	Viatris Inc	32,111	$509,922
5	TEVA	Teva Pharmaceutical Industries Ltd	8,901	$301,565
6	HLN	Haleon plc	29,413	$274,422
7	ANIP	Ani Pharmaceuticals Inc	2,683	$222,098
8	TAK	Takeda Pharmaceutical Co Ltd This page	10,292	$164,979

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$164,979	10,292	+255.5%	Shares	Defined	2026-08-14
2026-03-31	$53,615	2,895	+39.2%	Shares	Sole	2026-05-15
2025-12-31	$32,427	2,080	-18.0%	Shares	Sole	2026-02-13
2025-09-30	$37,127	2,536	-51.0%	Shares	Sole	2025-11-10
2025-06-30	$80,036	5,177	+212.4%	Shares	Sole	2025-08-12
2025-03-31	$24,639	1,657	+3.8%	Shares	Sole	2025-05-15
2024-12-31	$21,144	1,597	-91.7%	Shares	Sole	2025-02-14
2021-06-30	$322,042	19,135	-8.5%	Shares	Sole	2021-07-19
2021-03-31	$381,670	20,902	+2.9%	Shares	Sole	2021-05-10
2020-12-31	$369,660	20,311	-4.3%	Shares	Sole	2021-02-16
2020-09-30	$378,707	21,228	-1.7%	Shares	Sole	2020-10-26
2020-06-30	$387,270	21,599	-10.8%	Shares	Sole	2020-07-27
2020-03-31	$367,462	24,207	—	Shares	Sole	2020-04-16
No filing history on record for this holder in this stock.